vs
DeFi Development Corp.（DFDV）与Protalix BioTherapeutics, Inc.（PLX）财务数据对比。点击上方公司名可切换其他公司
Protalix BioTherapeutics, Inc.的季度营收约是DeFi Development Corp.的2.0倍（$9.1M vs $4.6M），DeFi Development Corp.净利率更高（1211.4% vs -60.3%，领先1271.7%），DeFi Development Corp.同比增速更快（647.2% vs -49.9%），过去两年DeFi Development Corp.的营收复合增速更高（181.5% vs -6.7%）
ADD汽车设计开发曾是一家英国企业，因打造外观极具未来感的Nova组装套件车为人熟知。该公司1971年至1973年总部位于南安普敦，后迁至兰开夏郡阿克灵顿运营至1975年。公司停业后，Nova车型相关产权在1978年被西约克郡的Nova Cars收购，后续还曾有小批量生产。
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
DFDV vs PLX — 直观对比
营收规模更大
PLX
是对方的2.0倍
$4.6M
营收增速更快
DFDV
高出697.1%
-49.9%
净利率更高
DFDV
高出1271.7%
-60.3%
两年增速更快
DFDV
近两年复合增速
-6.7%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $4.6M | $9.1M |
| 净利润 | $56.0M | $-5.5M |
| 毛利率 | 98.1% | 49.4% |
| 营业利润率 | — | -51.1% |
| 净利率 | 1211.4% | -60.3% |
| 营收同比 | 647.2% | -49.9% |
| 净利润同比 | 11995.1% | -184.8% |
| 每股收益（稀释后） | $1.95 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DFDVPLX
| Q4 25 | — | $9.1M | ||
| Q3 25 | $4.6M | $17.9M | ||
| Q2 25 | $2.0M | $15.7M | ||
| Q1 25 | $287.2K | $10.1M | ||
| Q4 24 | $628.9K | $18.2M | ||
| Q3 24 | $619.0K | $18.0M | ||
| Q2 24 | $441.0K | $13.5M | ||
| Q1 24 | $411.1K | — |
净利润DFDVPLX
| Q4 25 | — | $-5.5M | ||
| Q3 25 | $56.0M | $2.4M | ||
| Q2 25 | $15.4M | $164.0K | ||
| Q1 25 | $-778.0K | $-3.6M | ||
| Q4 24 | $-487.0K | $6.5M | ||
| Q3 24 | $-471.0K | $3.2M | ||
| Q2 24 | $-805.0K | $-2.2M | ||
| Q1 24 | $-964.0K | — |
毛利率DFDVPLX
| Q4 25 | — | 49.4% | ||
| Q3 25 | 98.1% | 53.4% | ||
| Q2 25 | 98.6% | 62.5% | ||
| Q1 25 | — | 19.1% | ||
| Q4 24 | 98.8% | 78.7% | ||
| Q3 24 | 98.7% | 53.4% | ||
| Q2 24 | 98.2% | 29.8% | ||
| Q1 24 | 97.9% | — |
营业利润率DFDVPLX
| Q4 25 | — | -51.1% | ||
| Q3 25 | — | 11.9% | ||
| Q2 25 | — | 7.5% | ||
| Q1 25 | -307.5% | -41.0% | ||
| Q4 24 | -107.9% | 39.6% | ||
| Q3 24 | -73.3% | 22.2% | ||
| Q2 24 | -193.2% | -18.0% | ||
| Q1 24 | -247.7% | — |
净利率DFDVPLX
| Q4 25 | — | -60.3% | ||
| Q3 25 | 1211.4% | 13.2% | ||
| Q2 25 | 777.0% | 1.0% | ||
| Q1 25 | -270.9% | -35.8% | ||
| Q4 24 | -77.4% | 35.6% | ||
| Q3 24 | -76.1% | 18.0% | ||
| Q2 24 | -182.5% | -16.4% | ||
| Q1 24 | -234.5% | — |
每股收益（稀释后）DFDVPLX
| Q4 25 | — | $-0.06 | ||
| Q3 25 | $1.95 | $0.03 | ||
| Q2 25 | $0.84 | $0.00 | ||
| Q1 25 | $-0.55 | $-0.05 | ||
| Q4 24 | $0.55 | $0.10 | ||
| Q3 24 | $-0.05 | $0.03 | ||
| Q2 24 | $-0.08 | $-0.03 | ||
| Q1 24 | $-0.70 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4M | $14.7M |
| 总债务越低越好 | $131.4M | — |
| 股东权益账面价值 | $243.8M | $48.2M |
| 总资产 | $480.0M | $82.3M |
| 负债/权益比越低杠杆越低 | 0.54× | — |
8季度趋势，按日历期对齐
现金及短期投资DFDVPLX
| Q4 25 | — | $14.7M | ||
| Q3 25 | $1.4M | $13.6M | ||
| Q2 25 | $595.0K | $17.9M | ||
| Q1 25 | $2.2M | $19.5M | ||
| Q4 24 | $2.8M | $19.8M | ||
| Q3 24 | $2.8M | $27.4M | ||
| Q2 24 | $3.2M | $23.4M | ||
| Q1 24 | $3.9M | — |
总债务DFDVPLX
| Q4 25 | — | — | ||
| Q3 25 | $131.4M | — | ||
| Q2 25 | $21.2M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益DFDVPLX
| Q4 25 | — | $48.2M | ||
| Q3 25 | $243.8M | $52.9M | ||
| Q2 25 | $79.6M | $49.9M | ||
| Q1 25 | $2.8M | $45.2M | ||
| Q4 24 | $3.5M | $43.2M | ||
| Q3 24 | $4.0M | $32.4M | ||
| Q2 24 | $4.3M | $28.6M | ||
| Q1 24 | $5.0M | — |
总资产DFDVPLX
| Q4 25 | — | $82.3M | ||
| Q3 25 | $480.0M | $82.3M | ||
| Q2 25 | $107.2M | $78.5M | ||
| Q1 25 | $4.2M | $73.9M | ||
| Q4 24 | $4.4M | $73.4M | ||
| Q3 24 | $4.5M | $61.6M | ||
| Q2 24 | $4.8M | $91.5M | ||
| Q1 24 | $5.5M | — |
负债/权益比DFDVPLX
| Q4 25 | — | — | ||
| Q3 25 | 0.54× | — | ||
| Q2 25 | 0.27× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.0M | $2.0M |
| 自由现金流经营现金流 - 资本支出 | — | $1.6M |
| 自由现金流率自由现金流/营收 | — | 17.8% |
| 资本支出强度资本支出/营收 | 0.0% | 4.4% |
| 现金转化率经营现金流/净利润 | -0.09× | — |
| 过去12个月自由现金流最近4个季度 | — | $-13.6M |
8季度趋势，按日历期对齐
经营现金流DFDVPLX
| Q4 25 | — | $2.0M | ||
| Q3 25 | $-5.0M | $-3.7M | ||
| Q2 25 | $-1.3M | $-5.2M | ||
| Q1 25 | $-785.6K | $-5.1M | ||
| Q4 24 | $-2.4M | $4.0M | ||
| Q3 24 | $-412.0K | $4.1M | ||
| Q2 24 | $-680.8K | $-3.6M | ||
| Q1 24 | $-1.1M | — |
自由现金流DFDVPLX
| Q4 25 | — | $1.6M | ||
| Q3 25 | — | $-4.2M | ||
| Q2 25 | — | $-5.7M | ||
| Q1 25 | — | $-5.4M | ||
| Q4 24 | $-2.4M | $3.6M | ||
| Q3 24 | — | $4.0M | ||
| Q2 24 | $-687.4K | $-3.8M | ||
| Q1 24 | $-1.2M | — |
自由现金流率DFDVPLX
| Q4 25 | — | 17.8% | ||
| Q3 25 | — | -23.7% | ||
| Q2 25 | — | -36.2% | ||
| Q1 25 | — | -53.0% | ||
| Q4 24 | -388.2% | 19.6% | ||
| Q3 24 | — | 22.4% | ||
| Q2 24 | -155.9% | -28.1% | ||
| Q1 24 | -280.3% | — |
资本支出强度DFDVPLX
| Q4 25 | — | 4.4% | ||
| Q3 25 | 0.0% | 2.8% | ||
| Q2 25 | — | 2.8% | ||
| Q1 25 | — | 3.0% | ||
| Q4 24 | 3.7% | 2.3% | ||
| Q3 24 | 0.0% | 0.5% | ||
| Q2 24 | 1.5% | 1.3% | ||
| Q1 24 | 1.6% | — |
现金转化率DFDVPLX
| Q4 25 | — | — | ||
| Q3 25 | -0.09× | -1.58× | ||
| Q2 25 | -0.08× | -31.91× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DFDV
| Digital Asset Treasury | $3.8M | 82% |
| Other | $831.0K | 18% |
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
